Concepts (252)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Alzheimer Disease | 9 | 2026 | 1001 | 2.290 |
Why?
|
| Mortality | 5 | 2019 | 175 | 1.960 |
Why?
|
| Cardiovascular Diseases | 5 | 2022 | 749 | 1.560 |
Why?
|
| Health Status | 4 | 2020 | 442 | 1.390 |
Why?
|
| Social Support | 5 | 2016 | 445 | 1.350 |
Why?
|
| Social Class | 5 | 2017 | 291 | 1.180 |
Why?
|
| Staphylococcal Infections | 3 | 2023 | 67 | 1.070 |
Why?
|
| Brain | 4 | 2025 | 1472 | 1.050 |
Why?
|
| Peptide Fragments | 2 | 2026 | 307 | 0.970 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 2 | 2023 | 67 | 0.910 |
Why?
|
| Microglia | 2 | 2026 | 208 | 0.910 |
Why?
|
| Prescription Drugs | 1 | 2025 | 32 | 0.900 |
Why?
|
| Carrier State | 3 | 2023 | 33 | 0.900 |
Why?
|
| Stroke | 2 | 2023 | 340 | 0.850 |
Why?
|
| Blood-Brain Barrier | 1 | 2026 | 173 | 0.850 |
Why?
|
| Staphylococcus aureus | 3 | 2023 | 94 | 0.840 |
Why?
|
| Common Cold | 1 | 2023 | 5 | 0.800 |
Why?
|
| Glutamic Acid | 1 | 2023 | 131 | 0.770 |
Why?
|
| Endothelial Cells | 1 | 2026 | 329 | 0.760 |
Why?
|
| Humans | 42 | 2026 | 43102 | 0.750 |
Why?
|
| Health Status Indicators | 3 | 2008 | 90 | 0.740 |
Why?
|
| Middle Aged | 23 | 2025 | 12222 | 0.730 |
Why?
|
| Interpersonal Relations | 2 | 2014 | 222 | 0.720 |
Why?
|
| Caregivers | 1 | 2024 | 197 | 0.700 |
Why?
|
| Male | 30 | 2026 | 23409 | 0.690 |
Why?
|
| Health Services Accessibility | 2 | 2024 | 706 | 0.680 |
Why?
|
| Glucose Transporter Type 1 | 1 | 2020 | 20 | 0.660 |
Why?
|
| Female | 30 | 2026 | 24698 | 0.650 |
Why?
|
| Rural Population | 2 | 2023 | 373 | 0.640 |
Why?
|
| Educational Status | 2 | 2020 | 339 | 0.640 |
Why?
|
| Adult | 23 | 2025 | 13872 | 0.620 |
Why?
|
| Forecasting | 1 | 2020 | 136 | 0.600 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2024 | 497 | 0.590 |
Why?
|
| Cross-Sectional Studies | 10 | 2023 | 3156 | 0.570 |
Why?
|
| Astrocytes | 1 | 2020 | 244 | 0.570 |
Why?
|
| Blood Glucose | 1 | 2020 | 389 | 0.560 |
Why?
|
| Aged | 15 | 2025 | 8214 | 0.510 |
Why?
|
| LDL-Receptor Related Proteins | 1 | 2016 | 10 | 0.510 |
Why?
|
| Presenilin-1 | 1 | 2016 | 28 | 0.500 |
Why?
|
| Nutrition Surveys | 5 | 2022 | 263 | 0.480 |
Why?
|
| Risk Factors | 8 | 2025 | 3994 | 0.480 |
Why?
|
| United States | 12 | 2024 | 5205 | 0.480 |
Why?
|
| Spouses | 1 | 2016 | 38 | 0.470 |
Why?
|
| Social Behavior | 1 | 2017 | 161 | 0.470 |
Why?
|
| Central Nervous System | 1 | 2016 | 152 | 0.440 |
Why?
|
| Social Environment | 2 | 2011 | 218 | 0.430 |
Why?
|
| Loneliness | 1 | 2014 | 24 | 0.410 |
Why?
|
| Depression | 3 | 2022 | 863 | 0.400 |
Why?
|
| NF-kappa B | 1 | 2016 | 358 | 0.390 |
Why?
|
| Cells, Cultured | 4 | 2026 | 1621 | 0.390 |
Why?
|
| Arizona | 3 | 2023 | 139 | 0.350 |
Why?
|
| Mutation | 1 | 2016 | 1177 | 0.350 |
Why?
|
| Mice, Transgenic | 3 | 2020 | 665 | 0.350 |
Why?
|
| Gene Expression Regulation | 1 | 2016 | 1070 | 0.330 |
Why?
|
| Serine Endopeptidases | 2 | 2023 | 48 | 0.320 |
Why?
|
| Prospective Studies | 4 | 2020 | 1600 | 0.320 |
Why?
|
| Extracellular Matrix Proteins | 2 | 2023 | 78 | 0.310 |
Why?
|
| Coronary Disease | 2 | 2013 | 123 | 0.310 |
Why?
|
| Risk Assessment | 3 | 2022 | 863 | 0.300 |
Why?
|
| Mexican Americans | 2 | 2008 | 226 | 0.290 |
Why?
|
| Neoplasms | 1 | 2020 | 1377 | 0.290 |
Why?
|
| Neurons | 1 | 2016 | 1263 | 0.290 |
Why?
|
| Personal Satisfaction | 1 | 2008 | 76 | 0.280 |
Why?
|
| Social Identification | 1 | 2008 | 65 | 0.280 |
Why?
|
| Cause of Death | 2 | 2020 | 186 | 0.260 |
Why?
|
| Adolescent | 9 | 2013 | 6081 | 0.260 |
Why?
|
| Health Behavior | 2 | 2008 | 575 | 0.260 |
Why?
|
| Smoking | 3 | 2008 | 1024 | 0.250 |
Why?
|
| Mexico | 2 | 2023 | 298 | 0.250 |
Why?
|
| Racemases and Epimerases | 1 | 2026 | 2 | 0.240 |
Why?
|
| Animals | 8 | 2026 | 16992 | 0.240 |
Why?
|
| Overweight | 1 | 2008 | 249 | 0.240 |
Why?
|
| Coculture Techniques | 1 | 2026 | 109 | 0.240 |
Why?
|
| Unemployment | 1 | 2025 | 29 | 0.230 |
Why?
|
| Leisure Activities | 1 | 2025 | 41 | 0.230 |
Why?
|
| Biological Transport | 1 | 2026 | 204 | 0.230 |
Why?
|
| Gene Expression | 2 | 2020 | 701 | 0.230 |
Why?
|
| Aged, 80 and over | 4 | 2025 | 2853 | 0.230 |
Why?
|
| Affect | 1 | 2007 | 180 | 0.230 |
Why?
|
| Obesity | 4 | 2020 | 1151 | 0.220 |
Why?
|
| Self Concept | 1 | 2006 | 171 | 0.220 |
Why?
|
| Health Surveys | 3 | 2013 | 405 | 0.220 |
Why?
|
| Attitude to Health | 1 | 2007 | 338 | 0.210 |
Why?
|
| Antiporters | 1 | 2023 | 14 | 0.210 |
Why?
|
| Cystine | 1 | 2023 | 14 | 0.210 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2011 | 989 | 0.210 |
Why?
|
| Case-Control Studies | 2 | 2025 | 1285 | 0.200 |
Why?
|
| Proportional Hazards Models | 2 | 2016 | 518 | 0.200 |
Why?
|
| Feasibility Studies | 1 | 2024 | 259 | 0.200 |
Why?
|
| Military Personnel | 1 | 2024 | 110 | 0.200 |
Why?
|
| Oral Health | 1 | 2024 | 87 | 0.200 |
Why?
|
| Socioeconomic Factors | 2 | 2020 | 1234 | 0.190 |
Why?
|
| Social Desirability | 1 | 2002 | 6 | 0.190 |
Why?
|
| Personality Tests | 1 | 2002 | 7 | 0.190 |
Why?
|
| Child, Preschool | 2 | 2024 | 1546 | 0.180 |
Why?
|
| Cell Line | 1 | 2026 | 1410 | 0.180 |
Why?
|
| Patient Participation | 1 | 2023 | 94 | 0.180 |
Why?
|
| Anxiety Disorders | 1 | 2005 | 322 | 0.180 |
Why?
|
| Hypertension | 2 | 2006 | 835 | 0.180 |
Why?
|
| Risk | 2 | 2020 | 287 | 0.180 |
Why?
|
| N-Methylaspartate | 1 | 2022 | 59 | 0.180 |
Why?
|
| Serine | 1 | 2022 | 79 | 0.180 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 2 | 2023 | 16 | 0.180 |
Why?
|
| Patient Selection | 1 | 2023 | 205 | 0.170 |
Why?
|
| Statistics as Topic | 2 | 2016 | 123 | 0.170 |
Why?
|
| Dental Caries | 1 | 2022 | 57 | 0.170 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2022 | 135 | 0.170 |
Why?
|
| Infant, Newborn | 1 | 2024 | 972 | 0.170 |
Why?
|
| Violence | 1 | 2002 | 136 | 0.170 |
Why?
|
| Young Adult | 5 | 2025 | 5080 | 0.170 |
Why?
|
| Cohort Studies | 1 | 2025 | 1759 | 0.160 |
Why?
|
| Infant | 1 | 2024 | 1175 | 0.160 |
Why?
|
| Schools | 1 | 2002 | 283 | 0.160 |
Why?
|
| Ubiquitination | 1 | 2019 | 62 | 0.150 |
Why?
|
| Interleukin-1beta | 1 | 2019 | 75 | 0.150 |
Why?
|
| Weight Loss | 2 | 2012 | 137 | 0.150 |
Why?
|
| Sex Distribution | 1 | 2020 | 224 | 0.150 |
Why?
|
| Age Distribution | 1 | 2020 | 249 | 0.150 |
Why?
|
| Morbidity | 1 | 2019 | 97 | 0.150 |
Why?
|
| Indians, North American | 1 | 2022 | 192 | 0.150 |
Why?
|
| Signal Transduction | 3 | 2023 | 2157 | 0.150 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2019 | 91 | 0.150 |
Why?
|
| Nerve Tissue Proteins | 2 | 2023 | 386 | 0.150 |
Why?
|
| Follow-Up Studies | 2 | 2020 | 1067 | 0.150 |
Why?
|
| Survival Rate | 1 | 2020 | 355 | 0.150 |
Why?
|
| Insulin | 1 | 2020 | 258 | 0.140 |
Why?
|
| Mice, Inbred C57BL | 3 | 2026 | 1869 | 0.140 |
Why?
|
| Retrospective Studies | 1 | 2025 | 2544 | 0.140 |
Why?
|
| Defense Mechanisms | 1 | 1997 | 10 | 0.140 |
Why?
|
| Mice | 5 | 2026 | 6644 | 0.130 |
Why?
|
| tau Proteins | 2 | 2016 | 186 | 0.130 |
Why?
|
| Arousal | 1 | 1997 | 95 | 0.130 |
Why?
|
| Lysosomes | 1 | 2017 | 86 | 0.130 |
Why?
|
| Apolipoprotein E4 | 1 | 2017 | 67 | 0.130 |
Why?
|
| Amyloid Precursor Protein Secretases | 1 | 2016 | 35 | 0.130 |
Why?
|
| Fibrinogen | 1 | 2016 | 24 | 0.130 |
Why?
|
| Telomere | 1 | 2017 | 59 | 0.120 |
Why?
|
| Age Factors | 1 | 2020 | 1154 | 0.120 |
Why?
|
| Uric Acid | 1 | 2016 | 29 | 0.120 |
Why?
|
| Glycoside Hydrolases | 1 | 2016 | 7 | 0.120 |
Why?
|
| TNF Receptor-Associated Factor 6 | 1 | 2016 | 4 | 0.120 |
Why?
|
| Cholesterol, LDL | 1 | 2016 | 73 | 0.120 |
Why?
|
| TNF Receptor-Associated Factor 2 | 1 | 2016 | 16 | 0.120 |
Why?
|
| Serum Albumin | 1 | 2016 | 59 | 0.120 |
Why?
|
| Aging | 1 | 2022 | 783 | 0.120 |
Why?
|
| Autophagy | 1 | 2017 | 140 | 0.120 |
Why?
|
| Sex Factors | 1 | 2020 | 1028 | 0.120 |
Why?
|
| Triglycerides | 1 | 2016 | 147 | 0.120 |
Why?
|
| Friends | 1 | 2016 | 25 | 0.120 |
Why?
|
| Transcription Factor RelA | 1 | 2016 | 42 | 0.120 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2015 | 29 | 0.120 |
Why?
|
| I-kappa B Kinase | 1 | 2016 | 51 | 0.120 |
Why?
|
| Body Mass Index | 3 | 2013 | 925 | 0.120 |
Why?
|
| Leukocytes | 1 | 2016 | 80 | 0.120 |
Why?
|
| C-Reactive Protein | 1 | 2016 | 167 | 0.120 |
Why?
|
| Language | 2 | 2025 | 185 | 0.110 |
Why?
|
| Embryo, Mammalian | 1 | 2016 | 157 | 0.110 |
Why?
|
| Amyloid beta-Protein Precursor | 1 | 2015 | 95 | 0.110 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2019 | 1766 | 0.110 |
Why?
|
| Switzerland | 1 | 2014 | 2 | 0.110 |
Why?
|
| Adaptation, Psychological | 1 | 1997 | 420 | 0.110 |
Why?
|
| Health Status Disparities | 1 | 2020 | 719 | 0.100 |
Why?
|
| RNA, Small Interfering | 1 | 2016 | 436 | 0.100 |
Why?
|
| Prognosis | 1 | 2016 | 861 | 0.100 |
Why?
|
| Retirement | 1 | 2013 | 13 | 0.100 |
Why?
|
| Hippocampus | 1 | 2016 | 594 | 0.100 |
Why?
|
| Quality of Life | 2 | 2008 | 616 | 0.090 |
Why?
|
| Depressive Disorder | 1 | 2014 | 187 | 0.090 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2020 | 760 | 0.090 |
Why?
|
| Telephone | 1 | 2012 | 36 | 0.090 |
Why?
|
| Multivariate Analysis | 1 | 2013 | 638 | 0.090 |
Why?
|
| Longevity | 1 | 2013 | 173 | 0.090 |
Why?
|
| Population Surveillance | 1 | 2011 | 246 | 0.080 |
Why?
|
| Odds Ratio | 1 | 2011 | 587 | 0.080 |
Why?
|
| Prevalence | 2 | 2025 | 1612 | 0.080 |
Why?
|
| Individuality | 2 | 2021 | 54 | 0.080 |
Why?
|
| Disease Models, Animal | 2 | 2026 | 1596 | 0.070 |
Why?
|
| Personal Autonomy | 1 | 2008 | 22 | 0.070 |
Why?
|
| Adiposity | 2 | 2008 | 157 | 0.070 |
Why?
|
| Rats | 1 | 2016 | 3735 | 0.070 |
Why?
|
| Interviews as Topic | 2 | 2006 | 452 | 0.070 |
Why?
|
| Sick Role | 1 | 2007 | 9 | 0.060 |
Why?
|
| Thinking | 1 | 2007 | 37 | 0.060 |
Why?
|
| Patients | 1 | 2006 | 16 | 0.060 |
Why?
|
| Emigrants and Immigrants | 1 | 2008 | 158 | 0.060 |
Why?
|
| Marital Status | 1 | 2006 | 46 | 0.060 |
Why?
|
| Mental Recall | 1 | 2006 | 84 | 0.060 |
Why?
|
| Health Promotion | 1 | 2012 | 704 | 0.060 |
Why?
|
| Phagocytosis | 1 | 2026 | 86 | 0.060 |
Why?
|
| Causality | 1 | 2005 | 45 | 0.060 |
Why?
|
| Motor Activity | 1 | 2008 | 437 | 0.060 |
Why?
|
| Mood Disorders | 1 | 2006 | 54 | 0.060 |
Why?
|
| Risk-Taking | 1 | 2008 | 457 | 0.060 |
Why?
|
| Models, Molecular | 2 | 2019 | 876 | 0.060 |
Why?
|
| Stress Disorders, Traumatic, Acute | 1 | 2024 | 2 | 0.060 |
Why?
|
| Norway | 1 | 2024 | 10 | 0.060 |
Why?
|
| Histones | 1 | 2026 | 197 | 0.050 |
Why?
|
| Cholesterol | 1 | 2006 | 232 | 0.050 |
Why?
|
| Anxiety | 2 | 2006 | 874 | 0.050 |
Why?
|
| Nasal Cavity | 1 | 2023 | 10 | 0.050 |
Why?
|
| Protein Binding | 2 | 2017 | 1082 | 0.050 |
Why?
|
| Luciferases | 1 | 2023 | 71 | 0.050 |
Why?
|
| Receptors, LDL | 1 | 2023 | 42 | 0.050 |
Why?
|
| Peer Group | 1 | 2024 | 177 | 0.050 |
Why?
|
| Phosphorylation | 2 | 2016 | 986 | 0.050 |
Why?
|
| Mice, Knockout | 1 | 2026 | 1035 | 0.050 |
Why?
|
| Waist Circumference | 2 | 2013 | 90 | 0.050 |
Why?
|
| Factor Analysis, Statistical | 1 | 2002 | 162 | 0.050 |
Why?
|
| Mass Media | 1 | 2002 | 39 | 0.050 |
Why?
|
| Mass Screening | 1 | 2006 | 541 | 0.040 |
Why?
|
| Psychometrics | 1 | 2002 | 358 | 0.040 |
Why?
|
| Sleep | 1 | 2021 | 185 | 0.040 |
Why?
|
| Ubiquitin | 1 | 2019 | 81 | 0.040 |
Why?
|
| Cognition | 1 | 2023 | 473 | 0.040 |
Why?
|
| Protein Transport | 1 | 2019 | 296 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2002 | 1081 | 0.040 |
Why?
|
| Enzyme Activation | 1 | 2019 | 462 | 0.040 |
Why?
|
| Community-Based Participatory Research | 1 | 2022 | 352 | 0.030 |
Why?
|
| Galvanic Skin Response | 1 | 1997 | 17 | 0.030 |
Why?
|
| Apolipoprotein E3 | 1 | 2017 | 12 | 0.030 |
Why?
|
| Epistasis, Genetic | 1 | 2017 | 19 | 0.030 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2017 | 20 | 0.030 |
Why?
|
| Cell Line, Transformed | 1 | 2017 | 95 | 0.030 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2017 | 54 | 0.030 |
Why?
|
| Intermediate Filament Proteins | 1 | 2016 | 16 | 0.030 |
Why?
|
| Detergents | 1 | 2016 | 25 | 0.030 |
Why?
|
| 14-3-3 Proteins | 1 | 2016 | 21 | 0.030 |
Why?
|
| Heart Rate | 1 | 1997 | 266 | 0.030 |
Why?
|
| Solubility | 1 | 2016 | 139 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2016 | 189 | 0.030 |
Why?
|
| Cell Death | 1 | 2016 | 278 | 0.030 |
Why?
|
| Computer Simulation | 1 | 2017 | 408 | 0.030 |
Why?
|
| Disease Progression | 1 | 2017 | 667 | 0.030 |
Why?
|
| Genotype | 1 | 2017 | 800 | 0.030 |
Why?
|
| Proteomics | 1 | 2016 | 378 | 0.030 |
Why?
|
| Child | 1 | 2002 | 3443 | 0.030 |
Why?
|
| Cytokines | 1 | 2017 | 678 | 0.030 |
Why?
|
| Personality Assessment | 1 | 2013 | 45 | 0.020 |
Why?
|
| Canada | 1 | 2013 | 163 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2017 | 1271 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2015 | 1124 | 0.020 |
Why?
|
| Students | 1 | 1997 | 626 | 0.020 |
Why?
|
| Energy Intake | 1 | 2012 | 164 | 0.020 |
Why?
|
| Incidence | 1 | 2013 | 1078 | 0.020 |
Why?
|
| Diet, Reducing | 1 | 2008 | 23 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2015 | 2676 | 0.020 |
Why?
|
| Anthropometry | 1 | 2008 | 97 | 0.020 |
Why?
|
| Behavior Therapy | 1 | 2008 | 180 | 0.020 |
Why?
|
| Utah | 1 | 2006 | 10 | 0.020 |
Why?
|
| Patient Education as Topic | 1 | 2008 | 235 | 0.020 |
Why?
|
| Decision Making | 1 | 2008 | 249 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2008 | 1604 | 0.010 |
Why?
|